Literature DB >> 21336465

Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis.

Adam T Hill1, Mark Pasteur, Charles Cornford, Sally Welham, Diana Bilton.   

Abstract

The British Thoracic Society (BTS) has recently published a guideline for the management of non-cystic fibrosis (non-CF) bronchiectasis in children and adults. This paper summarises the key recommendations applicable to the primary care setting. The key points are: • Think of the diagnosis of bronchiectasis in adults and children who present with a chronic productive cough or unexplained haemoptysis, and in children with asthma which responds poorly to treatment; • High resolution computed tomography (HRCT) scanning is needed to confirm the diagnosis • Sputum culture should be obtained at the start of an exacerbation prior to initiating treatment with antibiotics; Treatment should be started whilst awaiting the sputum result and should be continued for 14 days; • Patients with bronchiectasis have significant morbidity. Management in primary care is aimed at improving morbidity, and includes; patient education, treatment and monitoring, as well as appropriate referral to secondary care including assessment for long term antibiotics.

Entities:  

Mesh:

Year:  2011        PMID: 21336465      PMCID: PMC6549837          DOI: 10.4104/pcrj.2011.00007

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  24 in total

Review 1.  Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Authors:  Emma J Welsh; David J Evans; Stephen J Fowler; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

Review 2.  New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.

Authors:  R Ameratunga; S-T Woon; D Gillis; W Koopmans; R Steele
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

3.  Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?

Authors:  Hulya Nilgun Gurses; Hikmet Ucgun; Melih Zeren; Hilal Denizoglu Kulli; Erkan Cakır
Journal:  Eur J Pediatr       Date:  2022-05-20       Impact factor: 3.860

Review 4.  Airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2015-11-23

5.  Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.

Authors:  Robert Wilson; Tobias Welte; Eva Polverino; Anthony De Soyza; Hugh Greville; Anne O'Donnell; Jeff Alder; Peter Reimnitz; Barbara Hampel
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

Review 6.  Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.

Authors:  Yingmeng Ni; Guochao Shi; Youchao Yu; Jimin Hao; Tiantian Chen; Huihui Song
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-28

7.  Diagnostic yield of bronchial washing fluid analysis for hemoptysis in patients with bronchiectasis.

Authors:  Ju-Hee Park; Soo Jung Kim; Ae-Ra Lee; Jung-Kyu Lee; Junghyun Kim; Hyo-Jeong Lim; Young Jae Cho; Jong Sun Park; Ho Il Yoon; Jae-Ho Lee; Choon-Taek Lee; Sei Won Lee
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

8.  Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis.

Authors:  Jifeng Liu; Xiaoning Zhong; Zhiyi He; Lianghong Wei; Xiaozhen Zheng; Jianquan Zhang; Jing Bai; Wei Zhong; Dengjun Zhong
Journal:  Mediators Inflamm       Date:  2014-11-04       Impact factor: 4.711

9.  Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.

Authors:  J Minov; J Karadzinska-Bislimovska; K Vasilevska; S Stoleski; D Mijakoski
Journal:  Open Respir Med J       Date:  2015-03-31

Review 10.  The challenge of chronic lung disease in HIV-infected children and adolescents.

Authors:  Heinrich C Weber; Robert P Gie; Mark F Cotton
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.